– For immediate release –
Commending Michael Jackson’s ‘pioneer vision of cloning,’
LAS VEGAS, July 8 – After fielding numerous inquiries about the possible cloning of Michael Jackson, Dr. Brigitte Boisselier, head of Clonaid, today reaffirmed the company’s policy of strictly respecting the privacy of each of its patients.
“Clonaid prides itself on never releasing the identity of the numerous individuals who have been cloned in the past six years,” Boisselier said. “Even if that policy has been at the cost of my reputation, it’s important for us that the celebrities and other interested parties contacting us know they won’t be betrayed.”
Boisselier expressed admiration for Michael Jackson as an artist and also commended his courage in expressing support for human cloning at a time when it was getting much negative publicity in the press.
“Michael was a visionary who wasn’t afraid to embrace new technologies,” she said. “I’m glad his interest in cloning is being revealed now, since he was a pioneer in his views about it back in 2002 and his fans ought to know about it.”
“Human cloning is still making headlines six years after the birth of the first clone child,” Boisselier added. “But even if the media still present it as being too controversial, the public is much less afraid of it than it was initially. People have gotten used to the idea to the point where many see it as highly desirable. ”
She said that although the Clonaid team has received cloning requests from around the world, a surprisingly large number come from the Los Angeles/Hollywood area.
“Artists welcome our technology and have given us tremendous encouragement,” Boisselier noted. “Thanks to them, the public is getting more accustomed to the idea and hopefully the bans will soon be removed.”
She said Clonaid’s sister company, Stemaid, has launched an anti-aging program using stem cells derived from clone embryos.
“This development is also getting a good reception in the artists’ community,” she said.